Jasper Therapeutics
JSPR
JSPR
40 hedge funds and large institutions have $63.7M invested in Jasper Therapeutics in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
46% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 13
47% less capital invested
Capital invested by funds: $120M → $63.7M (-$56.3M)
Holders
40
Holding in Top 10
2
Calls
$98K
Puts
–
Top Buyers
| 1 | +$989K | |
| 2 | +$971K | |
| 3 | +$650K | |
| 4 |
ABG
Ally Bridge Group
New York
|
+$439K |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$368K |
Top Sellers
| 1 | -$943K | |
| 2 | -$685K | |
| 3 | -$671K | |
| 4 |
AAA
Affinity Asset Advisors
New York
|
-$653K |
| 5 |
Legal & General Group
London,
United Kingdom
|
-$110K |